These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 1559298)

  • 1. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
    Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy.
    Ciccarelli E; Ghigo E; Miola C; Gandini G; Muller EE; Camanni F
    Clin Endocrinol (Oxf); 1990 May; 32(5):583-92. PubMed ID: 2114241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia.
    Sawers HA; Robb OJ; Walmsley D; Strachan FM; Shaw J; Bevan JS
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):321-6. PubMed ID: 9156042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered dopaminergic regulation of thyrotrophin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function.
    Scanlon MF; Rodriguez-Arnao MD; McGregor AM; Weightman D; Lewis M; Cook DB; Gomez-Pan A; Hall R
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):133-43. PubMed ID: 6790201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
    Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
    De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
    Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
    Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
    Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
    Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre- and post-operative hypothalamic-pituitary-thyroidal axis function in patients with prolactinoma, growth hormone tumour and ACTH tumour.
    Lu C; Lin XT; Yang DT; Liu YC; He WT; Zhong XL
    Chin Med J (Engl); 1989 Apr; 102(4):306-12. PubMed ID: 2551602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma.
    Adriaanse R; Brabant G; Endert E; Bemelman FJ; Wiersinga WM
    Eur J Endocrinol; 1994 Feb; 130(2):113-20. PubMed ID: 8130883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P; Laws ER; Elliott E
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
    Valensi P; Combes ME; Perret G; Attali JR
    J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.
    Amar AP; Couldwell WT; Chen JC; Weiss MH
    J Neurosurg; 2002 Aug; 97(2):307-14. PubMed ID: 12186458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin-secreting pituitary adenomas: prolactin dynamics before and after transsphenoidal surgery.
    Barbarino A; de Marinis L; Menini E; Anile C; Maira G
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):397-409. PubMed ID: 112818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
    Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
    Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
    Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.